767 — Zhong Ji Longevity Science Share Price
Last trade - 00:00- HK$289.66m
- HK$287.65m
- HK$166.18m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.78 | ||
| Price to Tang. Book | 0.78 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.74 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7.84% | ||
| Return on Equity | -8.94% | ||
| Operating Margin | -19.04% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 80.02 | 61.12 | 89.67 | 64.99 | 166.18 | n/a | n/a | 2.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zhong Ji Longevity Science Group Ltd, formerly Asia Pacific Silk Road Investment Co Ltd, is an investment holding company principally engaged in the longevity science and money lending business. The Company mainly operates its business through five segments. The Longevity Science segment is engaged in longevity science research, longevity medical testing, longevity biological products, longevity management services and member division. The Money Lending segment is engaged in the money lending business and the provision of credits. The Securities and Other Investment segment is mainly engaged in the holding of equity investments and investment in short to long-term financial assets. The Property Investment segment is mainly engaged in the investment in properties for rental income and for potential capital appreciation. The Financial and Investment Advisory segment is mainly engaged in the provision of financial and investment consulting services.
Directors
- Yan Li CHM (49)
- Jiuhua Li CEO (58)
- Hongxin Wang CIN (57)
- Hon Siang Chin CTR (51)
- Qiong Cao Xie EDR (52)
- Xiaoshuang Li EDR (47)
- Wai Kin Liu SEC
- Ngai Wah Choi NED (63)
- Yiwu He NED (58)
- Nan Chai NID (37)
- Ho Leung Tam NID (48)
- Weixia Wang NID (39)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 9th, 1994
- Public Since
- November 20th, 1995
- No. of Employees
- 55
- Sector
- Banking Services
- Industry
- Financials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 546,529,549
- Address
- Room 1802,
- Web
- https://zhongji.com.hk/
- Phone
- +852 null25265778
- Auditors
- Elite Partners CPA Limited
Upcoming Events for 767
Similar to 767
Agricultural Bank of China
Stock Exchange of Hong Kong Limited
Aeon Credit Service Asia Co
Stock Exchange of Hong Kong Limited
Allied
Stock Exchange of Hong Kong Limited
Alliance International Education Leasing Holdings
Stock Exchange of Hong Kong Limited
Amasse Capital Holdings
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 24:16 UTC, shares in Zhong Ji Longevity Science are trading at HK$0.53. This share price information is delayed by 15 minutes.
Shares in Zhong Ji Longevity Science last closed at HK$0.53 and the price had moved by +63.08% over the past 365 days. In terms of relative price strength the Zhong Ji Longevity Science share price has outperformed the FTSE Developed Asia Pacific Index by +54.06% over the past year.
There is no consensus recommendation for this security.
Find out moreZhong Ji Longevity Science does not currently pay a dividend.
Zhong Ji Longevity Science does not currently pay a dividend.
Zhong Ji Longevity Science does not currently pay a dividend.
To buy shares in Zhong Ji Longevity Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.53, shares in Zhong Ji Longevity Science had a market capitalisation of HK$289.66m.
Here are the trading details for Zhong Ji Longevity Science:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 767
Based on an overall assessment of its quality, value and momentum Zhong Ji Longevity Science is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zhong Ji Longevity Science. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +164.31%.
As of the last closing price of HK$0.53, shares in Zhong Ji Longevity Science were trading +72.24% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Zhong Ji Longevity Science PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.53.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Zhong Ji Longevity Science's management team is headed by:
- Yan Li - CHM
- Jiuhua Li - CEO
- Hongxin Wang - CIN
- Hon Siang Chin - CTR
- Qiong Cao Xie - EDR
- Xiaoshuang Li - EDR
- Wai Kin Liu - SEC
- Ngai Wah Choi - NED
- Yiwu He - NED
- Nan Chai - NID
- Ho Leung Tam - NID
- Weixia Wang - NID